Standard Family Office LLC - TARO PHARMACEUTICAL INDS LTD ownership

TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 73 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Standard Family Office LLC ownership history of TARO PHARMACEUTICAL INDS LTD
ValueSharesWeighting
Q3 2022$2,0000.0%550.0%0.00%
-95.0%
Q2 2022$2,000
-33.3%
55
-17.9%
0.02%
-25.9%
Q4 2021$3,000
-83.3%
67
-72.7%
0.03%
+575.0%
Q1 2021$18,0000.0%2450.0%0.00%0.0%
Q4 2020$18,0002450.00%
Other shareholders
TARO PHARMACEUTICAL INDS LTD shareholders Q2 2022
NameSharesValueWeighting ↓
HealthInvest Partners AB 85,205$9,416,0007.01%
FORT, L.P. 149,014$16,468,0005.67%
Strategic Global Advisors, LLC 80,231$11,336,0004.23%
MATTHEWS INTERNATIONAL CAPITAL MANAGEMENT LLC 701,900$77,567,0003.19%
Ativo Capital Management LLC 78,727$8,700,0002.01%
Analyst IMS Investment Management Services Ltd. 31,438$3,474,0001.47%
Parametrica Management Ltd 4,327$478,0001.32%
Freestone Capital Holdings, LLC 89,005$9,836,0000.90%
RPG Investment Advisory, LLC 19,580$2,163,0000.68%
MERITAGE PORTFOLIO MANAGEMENT 38,465$4,251,0000.47%
View complete list of TARO PHARMACEUTICAL INDS LTD shareholders